Clinical Trial Update: Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of a survivin long peptide vaccine in patients with metastatic neuroendocrine tumors has completed, assessing safety and preliminary activity in l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Carcinoid Tumor of the Lung
• Pancreatic Neuroendocrine Tumor
• Typical Carcinoid Tumor of the Lung

Drugs mentioned

• Survivin Long Peptide Vaccine (Survivin long peptide vaccine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lung Atypical Carcinoid Tumor, Lung Typical Carcinoid Tumor | Phase 1 | Status: COMPLETED